SLAMF7/CS1/CD319

CAT: 0544-MBS4381607-01Size: 0.02 mg (With BSA & Azide at 0.2mg/mL)Dry Ice: NoHazardous: No
CAT#:0544-MBS4381607-01Size:0.02 mg (With BSA & Azide at 0.2mg/mL)
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Gene Name
[SLAMF7]
NCBI Gene ID
57823
Reactivity
Human
Storage Conditions
Antibody with azide: store at 2 to 8 degree C.
Antibody without azide: store at -20 to -80 degree C.
Antibody is stable for 24 months. Non-hazardous. No MSDS required.
Specificity
CS1, also known as novel Ly9, SLAMF7, 19A24 or CRACC, is a homophilic cell surface receptor. It is a member of the SLAM (signaling lymphocytic activation molecule) family of receptors expressed on natural killer (NK) cells, T cells and stimulated B cells. CS1 contains immunoreceptor tyrosine-based switch motifs in its cytoplasmic domain but, unlike other SLAM receptors, it does not recruit SAP (SLAM-associated protein). In humans, CS1 activates NK cells through an EAT-2-mediated pathway that is SAP-independent. CS1 recruits and associates with EAT-2, a protein closely related to SAP. EAT-2 induces phosphorylation of CS1 which then, upon ligand binding, activates downstream cytotoxicity effectors PLC and PI 3K. In mice, the EAT-2 association with CS1 has an inhibitory effect on the activation of NK cells.
Other Gene Names
[SLAMF7; SLAMF7; 19A; CS1; CD319; CRACC; CS1; CRACC]
Short Name
[SLAMF7/CS1/CD319]
Other Product Names
[SLAM family member 7 isoform b; SLAM family member 7; SLAM family member 7; SLAM family member 7; CD2 subset 1; CD2-like receptor-activating cytotoxic cells; CRACC; Membrane protein FOAP-12; Novel Ly9; Protein 19A; CD_antigen: CD319]
NCBI GI Number
543583691
NCBI Accession Number
NP_001269517.1
NCBI GB Accession Number
NP_001269517.1
Uniprot Accession Number
Q9NQ25

Related Products

CatalogName
MBS4764240-01SLAMF7/CS1 Rabbit mAb
MBS6437731-01SLAMF7 (Signaling Lymphocytic Activation Molecule Family Member 7, 19A, CS1, CD319, CRACC) (HRP)
MBS6437727-01SLAMF7 (Signaling Lymphocytic Activation Molecule Family Member 7, 19A, CS1, CD319, CRACC) (AP)
MBS6437729-01SLAMF7 (Signaling Lymphocytic Activation Molecule Family Member 7, 19A, CS1, CD319, CRACC) (Biotin)
MBS6437730-01SLAMF7 (Signaling Lymphocytic Activation Molecule Family Member 7, 19A, CS1, CD319, CRACC) (FITC)
MBS6437728-01SLAMF7 (Signaling Lymphocytic Activation Molecule Family Member 7, 19A, CS1, CD319, CRACC) (APC)
MBS6437737-01SLAMF7 (Signaling Lymphocytic Activation Molecule Family Member 7, 19A, CS1, CD319, CRACC) (PE)
MBS9141830-01Recombinant Human SLAMF7/CD319 Protein
MBS9247216-01Anti-SLAMF7/CS1 Reference Antibody (PDL241)
MBS9247218-01Anti-SLAMF7/CS1 Reference Antibody (elotuzumab)

Alternative Products

CatalogName
299124CRACC (CS1, Novel Ly9, SLAMF7, CD319)
251704SLAMF7 (SLAM Family Member 7, 19A, CD319, CRACC, CS1)
V8473-100UGSLAMF7 Antibody / CS1
C00779-01Anti-SLAMF7 / CS1
514242SLAMF7 (CS1) discontinued
ANT-11107-100ugCD319 / SLAMF7 Polyclonal Antibody
047992SLAMF7/CS1 (elotuzumab) discontinued
047990SLAMF7/CS1 (PDL241) discontinued
ANT-11106-50ugCD319 / SLAMF7 Monoclonal Antibody
A3062-1mg*5Anti-SLAMF7 / CS1 (PDL241)

Popular Products